Medicine Man Technologies, Inc. (SHWZ)
OTCMKTS · Delayed Price · Currency is USD
0.0022
0.00 (0.00%)
Nov 4, 2025, 4:00 PM EST
Medicine Man Technologies Revenue
Medicine Man Technologies had revenue of $43.24M in the quarter ending June 30, 2024, with 2.03% growth. This brings the company's revenue in the last twelve months to $174.91M, up 5.55% year-over-year. In the year 2023, Medicine Man Technologies had annual revenue of $172.45M with 8.20% growth.
Revenue (ttm)
174.91M
Revenue Growth
+5.55%
P/S Ratio
n/a
Revenue / Employee
222.81K
Employees
840
Market Cap
86.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 172.45M | 13.07M | 8.20% |
| Dec 31, 2022 | 159.38M | 50.96M | 47.00% |
| Dec 31, 2021 | 108.42M | 84.42M | 351.73% |
| Dec 31, 2020 | 24.00M | 13.38M | 126.03% |
| Dec 31, 2019 | 10.62M | 2.69M | 34.00% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| China New Energy Group Co. | 12.51M |
| Northwest Biotherapeutics | 1.09M |
Medicine Man Technologies News
- 11 months ago - Schwazze Provides Update on Delayed Filings - GlobeNewsWire
- 1 year ago - Medicine Man Technologies, Inc. (SHWZ) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Schwazze Sets Second Quarter 2024 Conference Call for August 13, 2024 at 5:00 p.m. ET - GlobeNewsWire
- 1 year ago - Schwazze Announces Restructuring of February 2025 Debt Obligations - GlobeNewsWire
- 1 year ago - Schwazze Announces Transition to OTC Expert Market and Provides Update on Delayed Filing - GlobeNewsWire
- 1 year ago - Schwazze Announces Grand Opening of its 35th New Mexico Dispensary in Bernalillo - GlobeNewsWire
- 1 year ago - Medicine Man Technologies, Inc. (SHWZ) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Schwazze Announces First Quarter 2024 Financial Results - PRNewsWire